Toll-like receptors 2 and 4: Initiators of non-septic inflammation in critical care medicine?

Intensive Care Medicine

Volumn 36, Issue 11, 2010, Pages 1826-1835

  Lorne, Emmanuel ^a,b   Dupont, Hervé ^a,b   Abraham, Edward ^c,d  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Critical care medicine; Ischemia reperfusion; Sterile inflammation; TLR2; TLR4; Trauma

Indexed keywords

HEAT SHOCK PROTEIN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ACUTE LUNG INJURY; BACTERIAL INFECTION; CELL ACTIVATION; CRITICAL ILLNESS; GENE ACTIVATION; GRAM POSITIVE BACTERIUM; HUMAN; INFLAMMATION; INTENSIVE CARE; MEMBRANE COMPONENT; PATHOPHYSIOLOGY; REVIEW; SEPSIS; SIGNAL TRANSDUCTION;

CRITICAL CARE; CRITICAL ILLNESS; HUMANS; INFLAMMATION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 78650418074     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-1983-5     Document Type: Review

References (84)

1. Gay NJ, Gangloff M (2007) Structure and function of Toll receptors and their ligands. Annu Rev Biochem 76:141-165
2. Vogel SN, Fitzgerald KA, Fenton MJ (2003) TLRs: Differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv 3:466-477
3. McGettrick AF, O'Neill LA (2004) The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction. Mol Immunol 41:577-582
4. Baeuerle PA, Baltimore D (1988) I kappa B: A specific inhibitor of the NFkappa B transcription factor. Science 242:540-546
5. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, Golenbock DT (2003) LPS-TLR4 signaling to IRF-3/7 and NF-kappa B involves the toll adapters TRAM and TRIF. J Exp Med 198:1043-1055
6. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189:1777-1782
7. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, Miyake K (2002) Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3:667-672
8. Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47-95
9. Shenkar R, Abraham E (1999) Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: Roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol 163:954-962
10. Tan LR, Waxman K, Clark L, Eloi L, Chhieng N, Miller B, Young A (1993) Superoxide dismutase and allopurinol improve survival in an animal model of hemorrhagic shock. Am Surg 59:797-800
11. Shiotani S, Shimada M, Taketomi A, Soejima Y, Yoshizumi T, Hashimoto K, Shimokawa H, Maehara Y (2007) Rhokinase as a novel gene therapeutic target in treatment of cold ischemia/ reperfusion-induced acute lethal liver injury: Effect on hepatocellular NADPH oxidase system. Gene Ther 14:1425-1433
12. Barsness KA, Arcaroli J, Harken AH, Abraham E, Banerjee A, Reznikov L, McIntyre RC (2004) Hemorrhageinduced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol 287:R592-R599
13. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T (2004) Reduced myocardial ischemiareperfusion injury in toll-like receptor 4-deficient mice. Circulation 109:784-789
14. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ (2007) TLR4 activation mediates kidney ischemia/ reperfusion injury. J Clin Invest 117:2847-2859
15. Benhamou Y, Favre J, Musette P, Renet S, Thuillez C, Richard V, Tamion F (2009) Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice. Crit Care Med 37:1724-1728
16. Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF, Thuillez C, Richard V (2007) Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 27:1064-1071
17. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van Der Poll T, Weening JJ, Florquin S (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115:2894-2903
18. Pulskens WP, Teske GJ, Butter LM, Roelofs JJ, van Der Poll T, Florquin S, Leemans JC (2008) Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/ reperfusion injury. PLoS One 3:e3596
19. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, Tobias PS, Mackman N, McKay DB (2007) TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88- dependent and -independent pathways. J Immunol 178:6252-6258
20. Abraham E, Singer M (2007) Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35:2408-2416
21. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, Leppert M, Matalon S, Munford R, Parsons P, Slutsky AS, Tracey KJ, Ward P, Gail DB, Harabin AL (2003) Future research directions in acute lung injury: Summary of a national heart, lung, and blood institute working group. Am J Respir Crit Care Med 167:1027-1035
22. Torres M, Forman HJ (2003) Redox signaling and the MAP kinase pathways. Biofactors 17:287-296
23. Schwartz MD, Repine JE, Abraham E (1995) Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock. Am J Respir Cell Mol Biol 12:434-440
24. Bowler RP, Arcaroli J, Abraham E, Patel M, Chang LY, Crapo JD (2003) Evidence for extracellular superoxide dismutase as a mediator of hemorrhageinduced lung injury. Am J Physiol Lung Cell Mol Physiol 284:L680-L687
25. Li Q, Bolli R, Qiu Y, Tang XL, Guo Y, French BA (2001) Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 103:1893-1898
26. Bowler RP, Arcaroli J, Crapo JD, Ross A, Slot JW, Abraham E (2001) Extracellular superoxide dismutase attenuates lung injury after hemorrhage. Am J Respir Crit Care Med 164:290-294
27. Shenkar R, Abraham E (1997) Hemorrhage induces rapid in vivo activation of CREB and NF-kappa B in murine intraparenchymal lung mononuclear cells. Am J Respir Cell Mol Biol 16:145-152
28. Lorne E, Zmijewski JW, Zhao X, Liu G, Tsuruta Y, Park YJ, Dupont H, Abraham E (2008) Role of extracellular superoxide in neutrophil activation: Interactions between xanthine oxidase and TLR4 induce proinflammatory cytokine production. Am J Physiol Cell Physiol 294:C985-C993
29. Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS (2004) Cutting edge: Direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharideinduced production of reactive oxygen species and activation of NF-kappa B. J Immunol 173:3589-3593
30. Yang CS, Shin DM, Kim KH, Lee ZW, Lee CH, Park SG, Bae YS, Jo EK (2009) NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. J Immunol 182:3696-3705
31. Cobb JP (2001) Nitric oxide synthase inhibition as therapy for sepsis: A decade of promise. Surg Infect (Larchmt) 2:93-100 (discussion 100-101)
32. Powers KA, Szaszi K, Khadaroo RG, Tawadros PS, Marshall JC, Kapus A, Rotstein OD (2006) Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med 203:1951-1961 (Pubitemid 44188469)
33. Murray LA, Knight DA, McAlonan L, Argentieri R, Joshi A, Shaheen F, Cunningham M, Alexopolou L, Flavell RA, Sarisky RT, Hogaboam CM (2008) Deleterious role of TLR3 during hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 178:1227-1237
34. Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, Hogaboam CM, Kunkel SL (2008) TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 205:2609-2621
35. Letarte PB, Lieberman K, Nagatani K, Haworth RA, Odell GB, Duff TA (1993) Hemin: Levels in experimental subarachnoid hematoma and effects on dissociated vascular smooth-muscle cells. J Neurosurg 79:252-255
36. Nath KA, Vercellotti GM, Grande JP, Miyoshi H, Paya CV, Manivel JC, Haggard JJ, Croatt AJ, Payne WD, Alam J (2001) Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1. Kidney Int 59:106-117
37. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G (2002) Pro-oxidant and cytotoxic effects of circulating heme. Blood 100:879-887
38. Figueiredo RT, Fernandez PL, Mourao- Sa DS, Porto BN, Dutra FF, Alves LS, Oliveira MF, Oliveira PL, Graca-Souza AV, Bozza MT (2007) Characterization of heme as activator of Toll-like receptor 4. J Biol Chem 282:20221-20229
39. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC (2002) Oligosaccharides of Hyaluronan activate dendritic cells via Toll-like receptor 4. J Exp Med 195:99-111
40. Agren UM, Tammi RH, Tammi MI (1997) Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic Biol Med 23:996-1001
41. Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, Gallo RL (2007) Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem 282:18265-18275
42. Teriete P, Banerji S, Noble M, Blundell CD, Wright AJ, Pickford AR, Lowe E, Mahoney DJ, Tammi MI, Kahmann JD, Campbell ID, Day AJ, Jackson DG (2004) Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell 13:483-496
43. Wang Q, Teder P, Judd NP, Noble PW, Doerschuk CM (2002) CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am J Pathol 161:2219-2228
44. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, Henson PM, Noble PW (2002) Resolution of lung inflammation by CD44. Science 296:155-158
45. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, Noble PW (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11:1173-1179
46. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251
47. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195
48. Sha Y, Zmijewski J, Xu Z, Abraham E (2008) HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 180:2531-2537
49. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ (2007) Toll-like receptor 9- dependent activation by DNAcontaining immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8:487-496
50. Ulloa L, Batliwalla FM, Andersson U, Gregersen PK, Tracey KJ (2003) High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis. Arthritis Rheum 48:876-881 (Pubitemid 36418228)
51. Peltz ED, Moore EE, Eckels PC, Damle SS, Tsuruta Y, Johnson JL, Sauaia A, Silliman CC, Banerjee A, Abraham E (2009) HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock 32:17-22
52. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ (2000) HMG-1 as a mediator of acute lung inflammation. J Immunol 165:2950-2954
53. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ (2004) Reversing established sepsis with antagonists of endogenous highmobility group box 1. Proc Natl Acad Sci USA 101:296-301
54. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290:C917-C924
55. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK (2002) Novel signal transduction pathway utilized by extracellular HSP70: Role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277:15028-15034
56. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, Wagner H (2001) Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/ interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 276:31332-31339
57. Hartl FU, Hayer-Hartl M (2002) Molecular chaperones in the cytosol: From nascent chain to folded protein. Science 295:1852-1858
58. Fink AL (1999) Chaperone-mediated protein folding. Physiol Rev 79:425-449
59. Qian SB, McDonough H, Boellmann F, Cyr DM, Patterson C (2006) CHIPmediated stress recovery by sequential ubiquitination of substrates and Hsp70. Nature 440:551-555
60. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12:1539-1546
61. Asea A (2007) Mechanisms of HSP72 release. J Biosci 32:579-584
62. Pittet JF, Lee H, Morabito D, Howard MB, Welch WJ, Mackersie RC (2002) Serum levels of Hsp 72 measured early after trauma correlate with survival. J Trauma 52:611-617 (discussion 617)
63. Febbraio MA, Ott P, Nielsen HB, Steensberg A, Keller C, Krustrup P, Secher NH, Pedersen BK (2002) Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. J Physiol 544:957-962
64. Tsan MF, Gao B (2004) Cytokine function of heat shock proteins. Am J Physiol Cell Physiol 286:C739-C744
65. Osterloh A, Veit A, Gessner A, Fleischer B, Breloer M (2008) Hsp60- mediated T cell stimulation is independent of TLR4 and IL-12. Int Immunol 20:433-443
66. Tsan MF, Gao B (2009) Heat shock proteins and immune system. J Leukoc Biol 85:905-910
67. Galloway E, Shin T, Huber N, Eismann T, Kuboki S, Schuster R, Blanchard J, Wong HR, Lentsch AB (2008) Activation of hepatocytes by extracellular heat shock protein 72. Am J Physiol Cell Physiol 295:C514-C520
68. Zou N, Ao L, Cleveland JC Jr, Yang X, Su X, Cai GY, Banerjee A, Fullerton DA, Meng X (2008) Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. Am J Physiol Heart Circ Physiol 294:H2805-H2813
69. Mullarkey M, Rose JR, Bristol J, Kawata T, Kimura A, Kobayashi S, Przetak M, Chow J, Gusovsky F, Christ WJ, Rossignol DP (2003) Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J Pharmacol Exp Ther 304:1093-1102
70. Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ, Agnew ML, Hampton CR, Rothnie CL, Spring DJ, Pohlman TH, Shimpo H, Verrier ED (2006) Inhibition of Tolllike receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 114:I270-I274
71. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF III (2001) The extra domain A of fibronectin activates Tolllike receptor 4. J Biol Chem 276:10229-10233
72. Kim HG, Lee SY, Kim NR, Ko MY, Lee JM, Yi TH, Chung SK, Chung DK (2008) Inhibitory effects of Lactobacillus plantarum lipoteichoic acid (LTA) on Staphylococcus aureus LTA-induced tumor necrosis factoralpha production. J Microbiol Biotechnol 18:1191-1196
73. Spyvee MR, Zhang H, Hawkins LD, Chow JC (2005) Toll-like receptor 2 antagonists. Part 1: Preliminary SAR investigation of novel synthetic phospholipids. Bioorg Med Chem Lett 15:5494-5498
74. Meng G, Rutz M, Schiemann M, Metzger J, Grabiec A, Schwandner R, Luppa PB, Ebel F, Busch DH, Bauer S, Wagner H, Kirschning CJ (2004) Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest 113:1473-1481
75. Takashima K, Matsunaga N, Yoshimatsu M, Hazeki K, Kaisho T, Uekata M, Hazeki O, Akira S, Iizawa Y, Ii M (2009) Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br J Pharmacol 157:1250-1262
76. Palsson-McDermott EM, Doyle SL, McGettrick AF, Hardy M, Husebye H, Banahan K, Gong M, Golenbock D, Espevik T, O'Neill LA (2009) TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway. Nat Immunol 10:579-586
77. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM (2008) Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133:235-249
78. Vaneker M, Joosten LA, Heunks LM, Snijdelaar DG, Halbertsma FJ, van Egmond J, Netea MG, van Der Hoeven JG, Scheffer GJ (2008) Low-tidalvolume mechanical ventilation induces a toll-like receptor 4-dependent inflammatory response in healthy mice. Anesthesiology 109:465-472
79. Blanco AM, Perez-Arago A, Fernandez-Lizarbe S, Guerri C (2008) Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/ TLR4 receptors via lipid rafts caveolae in astroglial cells. J Neurochem 106:625-639
80. Fernandez-Lizarbe S, Pascual M, Gascon MS, Blanco A, Guerri C (2008) Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages. Mol Immunol 45:2007-2016
81. Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG (2001) Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34:101-108 (Pubitemid 32591488)
82. Yohe HC, O'Hara KA, Hunt JA, Kitzmiller TJ, Wood SG, Bement JL, Bement WJ, Szakacs JG, Wrighton SA, Jacobs JM, Kostrubsky V, Sinclair PR, Sinclair JF (2006) Involvement of Tolllike receptor 4 in acetaminophen hepatotoxicity. Am J Physiol Gastrointest Liver Physiol 290:G1269-G1279
83. Genuneit J, Cantelmo JL, Weinmayr G, Wong GW, Cooper PJ, Riikjarv MA, Gotua M, Kabesch M, von Mutius E, Forastiere F, Crane J, Nystad W, El- Sharif N, Batlles-Garrido J, Garcia- Marcos L, Garcia-Hernandez G, Morales-Suarez-Varela M, Nilsson L, Braback L, Saraclar Y, Weiland SK, Cookson WO, Strachan D, Moffatt MF (2009) A multi-centre study of candidate genes for wheeze and allergy: The International Study of Asthma and Allergies in Childhood Phase 2. Clin Exp Allergy 39:1875-1888
84. Smit LA, Siroux V, Bouzigon E, Oryszczyn MP, Lathrop M, Demenais F, Kauffmann F (2009) CD14 and tolllike receptor gene polymorphisms, country living, and asthma in adults. Am J Respir Crit Care Med 179:363-368